Strides Pharma Science Limited

Web: strides.com NSE: STAR BSE: 532531 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

1059 5(1%)

Volume

2L as on 23, Jun

Open

701

High

701

Low

685

1,054

VWAP

1,122

52 Week High

1,231

52 Week Low

769

Viand Research Rating

Quality Score

58/100

Growth Score

68/100

Valuation Score

50/100

Momentum Score

20/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

9,761

No. of Shares

9.22

P/E

194.46

P/B

4.17

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

2.14

ROCE

Profit Growth

Listing Date

02-Feb-00

Promoter Holding

27.91%

FII Holding

28.4%

DII Holding

15.42%

Price Chart

Price Performance

1 Week1%

1 Month4%

3 Months22%

6 Months27%

1 Year27%

YTD27%

Moving Average

5 Day SMA1,111

10 Day SMA1,077

20 Day SMA1,077

30 Day SMA1,103

50 Day SMA1,082

61 Day SMA1,059

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	1,142	1,121	1,132	1,149
Resistance 2	1,132	1,120	1,125	1,136
Resistance 1	1,124	1,118	1,121	1,131
Pivot Point	1,114	1,116	1,114	1,118
Support 1	1,106	1,115	1,107	1,113
Support 2	1,096	1,113	1,103	1,100
Support 3	1,088	1,111	1,096	1,095

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,56,655	1899	0%	2%	9%	21%	37	57.7	0.07	11509
2	DIVISLAB	2,43,196	9161	2%	8%	44%	51%	69	57.7	0	2568
3	TORNTPHARM	1,84,303	4846	2%	3%	12%	36%	72	57.7	1.79	2138
4	APOLLOHOSP	1,24,834	8650	1%	1%	12%	10%	58	57.7	0.9	2003
5	ZYDUSLIFE	1,12,897	1132	4%	2%	26%	13%	20	57.7	0.46	5124
6	CIPLA	1,11,346	1385	2%	5%	3%	12%	22	57.7	0.02	3862
7	LAURUSLABS	99,634	1844	3%	3%	75%	114%	0	57.7	0.48	890
8	DRREDDY	96,962	1151	2%	2%	11%	8%	20	57.7	0.2	4158
9	MAXHEALTH	96,646	985	1%	10%	8%	14%	0	57.7	0.32	1442
10	LUPIN	96,620	2113	1%	11%	8%	10%	23	57.7	0.29	5355
Load More

Shareholding Pattern (%)

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 27.91%	(0.11) 27.91%	(0.01) 27.86%	(-0.41) 27.86%	(0.01) 28.30%	(1.51) 28.30%	(1.01) 26.82%	(0.01) 25.84%	(0.01) 25.86%	(-1.51) 25.88%	(-0.41) 27.39%	(-0.31) 27.79%	(-0.21) 28.08%	(-2.61) 28.28%	(-0.21) 30.90%	(0.71) 31.08%	(-0.21) 30.37%	(1.01) 30.60%	(0.01) 29.60%	(0.01) 29.60%
FIIs	(-0.31) 28.40%	(-0.81) 28.68%	(1.01) 29.52%	(0.51) 28.51%	(-0.31) 28.02%	(-0.21) 28.32%	(-1.61) 28.48%	(3.41) 30.08%	(2.11) 26.71%	(5.11) 24.57%	(2.21) 19.45%	(0.51) 17.25%	(-2.11) 16.72%	(-0.11) 18.85%	(-2.51) 18.98%	(0.21) 21.43%	(1.61) 21.21%	(-0.21) 19.66%	(-5.11) 19.85%	(0.01) 24.96%
DIIs	(1.01) 15.42%	(1.41) 14.44%	(0.01) 13.02%	(-0.31) 12.98%	(-0.41) 13.30%	(-3.21) 13.72%	(-1.31) 16.92%	(0.11) 18.24%	(0.51) 18.17%	(-1.41) 17.66%	(-0.51) 19.02%	(-0.11) 19.50%	(1.71) 19.60%	(-0.61) 17.88%	(3.41) 18.44%	(-1.61) 15.07%	(-2.21) 16.63%	(-2.31) 18.82%	(0.61) 21.08%	(0.01) 20.44%
Government	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.39%	0.39%	0.39%	0.40%	0.40%	0.40%	0.40%	0.40%	0.00%	0.00%	0.00%	0.00%
Public	28.28%	28.96%	29.59%	30.62%	30.38%	29.65%	27.78%	25.83%	28.87%	31.52%	33.75%	35.06%	35.22%	34.60%	31.29%	32.05%	31.79%	30.92%	29.47%	25.00%
No. of Shareholders	94,850	86,616	85,589	91,206	92,889	95,125	114,236	96,009	91,917	84,695	91,182	101,638	112,775	120,916	123,964	130,682	134,718	133,190	125,553	106,927

Quarterly Results

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	1265	1323	1195	1221	1120	1190	1154	1167	1054	1044	1006	999	930	986	865	897	940	866	794	721	688
Sales Growth % (YoY)	13%	11.2%	3.6%	4.6%	6.2%	14.1%	14.7%	16.8%	13.4%	5.8%	16.3%	11.4%	-1.1%	13.9%	8.9%	24.3%	36.6%	-4.7%	-4.5%	-9.1%	-12%
Sales Growth % (QoQ)	-4.4%	10.7%	-2.1%	9%	-5.9%	3.1%	-1.1%	10.7%	1%	3.8%	0.7%	7.4%	-5.7%	14%	-3.6%	-4.6%	8.5%	9.1%	10.1%	4.8%	-
Expenses	1037	1084	959	990	902	973	943	983	866	874	876	889	796	871	892	844	936	868	817	759	758
Operating Profit	228	240	236	231	218	218	210	184	188	169	129	111	134	115	-27	53	4	-1	-23	-37	-70
OPM %	18	18	20	19	19	18	18	16	18	16	13	11	14	12	-3	6	0	0	-3	-5	-10
Other Income	68	3	104	18	0	-12	4	25	3299	-27	60	-129	3	20	68	57	-52	9	-5	-38	-78
Interest	41	42	43	46	47	50	52	74	73	71	70	79	76	81	58	68	55	49	42	44	41
Depreciation	56	53	51	50	49	49	48	48	47	48	49	60	60	61	60	62	60	61	61	57	55
Profit before tax	200	148	245	153	122	106	114	86	3369	23	70	-157	0	-7	-78	-20	-163	-103	-131	-175	-244
Tax %	17	13	15	14	13	20	21	16	1	55	23	-5	3025	106	5	-197	-17	-128	-3	-4	-15
Net Profit	165	129	208	132	106	86	90	72	3350	10	54	-149	-9	-14	-82	19	-135	29	-127	-168	-209
Net Profit Growth % (QoQ)	27.9%	-38%	57.6%	24.5%	23.3%	-4.4%	25%	-97.9%	33400%	-81.5%	136.2%	-1555.6%	35.7%	82.9%	-531.6%	114.1%	-565.5%	122.8%	24.4%	19.6%	-
Net Profit Growth % (YoY)	55.7%	50%	131.1%	83.3%	-96.8%	760%	66.7%	148.3%	37322.2%	171.4%	165.9%	-884.2%	93.3%	-148.3%	35.4%	111.3%	35.4%	-	-	-	-
TTM Net Profit	634	575	532	414	354	3598	3522	3486	3265	-94	-118	-254	-86	-212	-169	-214	-401	-475	-504	-377	0
EPS in Rs	17.02	13.77	21.93	13.84	10.8	8.91	9.54	7.81	364.69	1.98	5.4	-14.54	-0.79	-1.06	-8.86	2.53	-15.13	3.25	-13.55	-18.1	-22.87

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Dec 2012	Jan 1900
Sales	4859	4565	3890	3688	3070	3316	2752	2178	2845	2755	2861	1196	1341	962	1341
Sales Growth %	6.4%	17.4%	5.5%	20.1%	-7.4%	20.5%	26.3%	-23.4%	3.2%	-3.7%	139.2%	-10.8%	39.4%	-62.3%	-
Expenses	3933	3763	3362	3544	3201	2779	2338	1982	2448	2228	2486	967	1567	861	1567
Operating Profit	925	803	528	145	-131	537	414	197	398	527	374	229	-226	101	-226
OPM %	19	18	14	3.9	-4.3	16	15	9	14	19	13	19	-17	10	-17
Other Income	124	3313	-100	92	-112	109	-43	303	643	291	63	874	3281	959	3281
Interest	179	249	280	261	177	150	156	79	196	183	168	47	109	79	109
Depreciation	202	192	214	243	233	206	174	117	154	126	131	64	56	31	56
Profit before tax	669	3675	-65	-268	-653	289	42	303	690	509	137	992	2890	949	2890
Tax %	14	2	45	-21	-27	11	27	-9	1	12	31	15	39	11	39
Net Profit	575	3598	-94	-212	-474	258	31	330	684	446	95	844	1767	847	1767
Net Profit Growth %	-84%	3927.7%	55.7%	55.3%	-283.7%	732.3%	-90.6%	-51.8%	53.4%	369.5%	-88.7%	-52.2%	108.6%	-52.1%	-
EPS in Rs	60.34	389.75	-7.68	-22.44	-51.25	29.93	4.06	36.27	74.25	44.71	12.15	141.78	296.43	143.92	296.43
Dividend Payout %	8	1	-33	-7	0	8	345	8	3	10	41	76	170	1	170

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Dec 2012
Cash from Operating Activity	703	684	701	44	-258	481	205	60	187	288	73	83	-272	139
Cash from Investing Activity	-173	-90	-150	302	-119	-522	1321	-145	570	-1222	-2205	50	4044	771
Cash from Financing Activity	-453	-643	-693	-214	421	-16	-1709	194	-1016	338	2944	-421	-3319	-990
Net Cash Flow	76	-48	-142	133	45	-56	-184	110	-259	-596	812	-288	454	-80

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Dec 2012
Equity Capital	92	92	92	92	92	90	90	90	90	90	90	89	89	60	60	59
Reserves	3015	2664	2460	2179	2034	2122	2269	2687	2438	2559	2374	2659	2569	1085	947	1967
Borrowings	1758	1844	1880	2308	2517	3030	3025	2348	2235	3221	2520	3700	3542	892	547	1594
Other Liabilities	1941	1921	1498	1410	1157	1352	1556	1844	1369	1937	1601	1598	1211	438	543	1175
Total Liabilities	6807	6521	5929	5990	5799	6594	6940	6969	6131	7807	6585	8046	7410	2475	2096	4796
Fixed Assets	2101	2139	1899	1987	1865	2311	2347	2219	2099	3648	2977	2980	2679	701	555	3017
CWIP	447	164	207	154	162	151	291	447	413	453	620	780	815	171	99	241
Investments	291	440	409	243	303	490	540	697	549	702	588	1525	1341	630	443	0
Other Assets	3967	3777	3414	3605	3470	3642	3762	3605	3070	3005	2400	2762	2576	972	999	1538
Total Assets	6807	6521	5929	5990	5799	6594	6940	6969	6131	7807	6585	8046	7410	2475	2096	4796

Delivery

Delivery Data: STAR

#	Date	931 22% 1138	Value (Cr)	Q/T 19	Del 41	Del 44
1	4-Sep	1060	23	15	48	11
2	3-Sep	1054	20	18	50	10
3	2-Sep	1048	34	18	53	18
4	1-Sep	1024	20	12	49	10
5	31-Aug	1025	44	18	48	21
6	28-Aug	1020	44	26	64	28
7	27-Aug	983	9	14	43	4
8	26-Aug	983	10	11	44	4
9	25-Aug	987	21	21	40	8
10	24-Aug	994	22	15	43	9
11	21-Aug	986	34	19	34	11
12	20-Aug	993	499	31	17	85
13	19-Aug	958	33	14	52	17
14	18-Aug	949	23	17	49	11
15	17-Aug	987	16	13	51	8
16	14-Aug	968	16	12	47	8
17	13-Aug	989	18	17	58	11
18	12-Aug	994	10	11	46	5
19	11-Aug	1003	19	14	48	9
20	10-Aug	999	15	16	50	8
21	7-Aug	1004	26	15	44	12
22	6-Aug	997	42	21	48	20
23	5-Aug	970	37	18	55	20
24	4-Aug	995	21	16	64	14
25	3-Aug	1028	48	19	42	20
26	31-Jul	1025	177	18	22	39
27	30-Jul	1073	15	10	43	6
28	29-Jul	1060	16	8	44	7
29	28-Jul	1042	9	8	48	5
30	27-Jul	1043	26	9	54	14
31	24-Jul	1020	8	8	48	4
32	23-Jul	1032	9	9	43	4
33	22-Jul	1041	29	12	47	14
34	21-Jul	1051	9	10	45	4
35	20-Jul	1060	14	11	51	7
36	17-Jul	1075	44	14	49	22
37	16-Jul	1049	16	12	61	10
38	15-Jul	1060	7	10	39	3
39	14-Jul	1071	7	10	38	3
40	13-Jul	1074	11	9	41	4
41	10-Jul	1083	33	14	49	16
42	9-Jul	1076	24	13	49	12
43	8-Jul	1081	12	10	49	6
44	7-Jul	1128	9	8	57	5
45	6-Jul	1122	7	10	42	3
46	3-Jul	1127	11	11	46	5
47	2-Jul	1126	21	12	44	9
48	1-Jul	1094	11	11	40	4
49	30-Jun	1093	22	16	55	12
50	29-Jun	1103	27	12	37	10

Daily Market Cap

Date	Total Market Cap	Change	Chg %
04-Sep	9,761c	5c	0.05
03-Sep	9,766c	414c	4.43
01-Sep	9,352c	25c	0.27
31-Aug	9,327c	193c	2.11
26-Aug	9,134c	55c	0.61
25-Aug	9,079c	91c	1.00
24-Aug	9,170c	124c	1.37
21-Aug	9,047c	244c	2.77
19-Aug	8,803c	55c	0.63
18-Aug	8,747c	374c	4.10
17-Aug	9,121c	199c	2.23
14-Aug	8,922c	256c	2.79
13-Aug	9,179c	54c	0.59
12-Aug	9,125c	96c	1.04
11-Aug	9,221c	5c	0.05
10-Aug	9,216c	30c	0.33
06-Aug	9,247c	273c	3.04
05-Aug	8,974c	113c	1.24
04-Aug	9,086c	226c	2.43
03-Aug	9,312c	182c	1.91
31-Jul	9,494c	533c	5.31
30-Jul	10,027c	345c	3.56
29-Jul	9,682c	96c	1.00
28-Jul	9,586c	9c	0.10
27-Jul	9,595c	230c	2.46
24-Jul	9,365c	0	0

Stock Checklist

Price is above from 52 week high low average: 63%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 33 fund scheme(s) across 11 fund house(s) as of Aug26 · Total value ₹1,666 Cr · 3 increasing / 16 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
quant Mutual Fund	6	1.27%	-0.07%	1057
Bandhan Mutual Fund	6	0.58%	-0.02%	328.4
Axis Mutual Fund	2	0.25%	-0.04%	150.7
Aditya Birla Sun Life Mutual Fund	2	0.56%	-0.03%	75.1
Motilal Oswal Mutual Fund	4	0.74%	-0.11%	36.2
WhiteOak Capital Mutual Fund	2	0.90%	-0.57%	12.7
Jio BlackRock Mutual Fund	1	0.09%	+0.09%	2.9
Samco Mutual Fund	4	0.33%	-	2.5
Groww Mutual Fund	2	0.03%	-	0.2
Mirae Asset Mutual Fund	2	0.04%	+0.01%	0
Angel One Mutual Fund	2	0.03%	-	0

Strides Pharma Science Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements